EUDA Health Holdings Ltd美股招股说明书(2026-06-11版)

EUDA HEALTH HOLDINGS LIMITED This prospectus supplement (this “Supplement”) amends and supplements the prospectus dated November 4, 2024 (the “BaseProspectus”), as amended and supplemented by the Prospectus Supplement dated June 24, 2025 and January 23, 2026, (collectively,the “Filed Prospectus Supplements”). This Supplement is qualified in its entirety by reference to the Base Prospectus, as amended andsupplemented to date, except to the extent that the information herein amends or supersedes the information contained therein. We filed the Filed Prospectus Supplements to register the offer and sale of shares of our ordinary shares, having an aggregate offeringprice of up to $10.0 million in an “at-the-market” offering (the “ATM Offering”) pursuant to the At The Market Offering Agreement,dated June 23, 2025 (the “ATM Agreement”), with Chardan Capital Markets, LLC (the “Manager”). We are filing this Supplement toamend and supplement the information in the Filed Prospectus Supplements to suspend the ATM Offering and reduce the maximumaggregate offering price of our ordinary shares that may be offered and sold under the ATM Agreement from and after the date hereofto zero. As of the date of this Supplement, no ordinary shares have been sold under the ATM Agreement or the Filed ProspectusSupplements. On June 5, 2026, we sent the Manager a notice to terminate the ATM Agreement and the ATM Offering. We will file a prospectussupplement to report the termination of the ATM Agreement and the ATM Offering, and to terminate all related prospectussupplements shortly after the effective date of the termination which is 30 business days from the date of the termination pursuant tothe terms of the ATM Agreement. Our Ordinary Shares are listed on the NASDAQ Capital Market under the symbol “EUDA”. On June 11, 2026, the closing price of ourOrdinary Shares on the Nasdaq Capital Market was US$15.50. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is acriminal offense. The date of this prospectus supplement is June 11, 2026.